| Authors: |
Burke MJ; Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada; Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: matt.burke@utoronto.ca., Sandra DA; Department of Clinical Psychological Science, University of Toronto, Toronto, ON, Canada., Peciña M; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Olson JA; Department of Psychology, University of Toronto, Toronto, ON, Canada., Mollica A; Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada., Butler M; Neuropsychiatry Research and Education Group, King's College London, London, UK., Moss JH; Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Nicholson TR; Neuropsychiatry Research and Education Group, King's College London, London, UK., Wager TD; Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH, USA., Kaptchuk TJ; Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. |
